Department of Clinical Pharmacy, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran.
Department of Pharmacology and Toxicology, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran.
Curr Drug Saf. 2022;17(3):259-268. doi: 10.2174/1574886316666211123101002.
The majority of research in medication reconciliation has focused on the inpatient settings, and little is known about the outpatient settings, particularly in developing countries. As such, we conducted this study to evaluate direct clinical pharmacist involvement in medication reconciliation in outpatient specialty clinics in Iran.
This prospective interventional study was conducted from September 2019 to February 2020 in a University-affiliated clinic in Iran. For 196 patients over 18 years of age who were scheduled for an appointment with a physician, medication reconciliation intervention was carried out by a clinical pharmacist. The number and type of unintentional discrepancies, their potential harm to the patients, their correlation with the patients' demographic and clinical characteristics, and the number of accepted recommendations upon the unintentional discrepancies by the clinicians were assessed and recorded. Additionally, patients' understanding of any change made to their current medication regimen was also assessed.
In total, 57.14% of patients had at least one or more unintentional medication discrepancies, with an overall rate of 1.51 (±0.62) per patient. This is while the patient understanding of their medication changes was inadequate in a significant proportion of the study patients (62.2%). Patients with older ages, lower educational levels, and a higher number of medications and comorbidities were at a higher risk of having unintentional discrepancies. The most common type of unintentional discrepancy was the omission of a drug, and almost half of the reconciliation errors might have had the potential to cause moderate or severe harm to the patient. From 145 recommendations suggested by the clinical pharmacist upon unintentional discrepancies, 131 cases (90.34%) were accepted and implemented by the clinicians.
These findings further support the need for conducting medication reconciliation in outpatient settings to identify discrepancies and enhance the safety of patient medication use.
大多数关于用药核对的研究都集中在住院环境中,而对于门诊环境,尤其是在发展中国家,了解甚少。因此,我们进行了这项研究,以评估直接参与伊朗门诊专科诊所用药核对的临床药师的作用。
这项前瞻性干预研究于 2019 年 9 月至 2020 年 2 月在伊朗一所大学附属医院进行。对 196 名 18 岁以上预约医生的患者,临床药师进行了用药核对干预。评估并记录了非故意差异的数量和类型、对患者的潜在危害、与患者人口统计学和临床特征的相关性,以及临床医生对非故意差异的建议的接受数量。此外,还评估了患者对其当前药物治疗方案的任何改变的理解程度。
共有 57.14%的患者至少存在一种或多种非故意用药差异,总体发生率为 1.51(±0.62)/人。而在研究患者中,相当一部分(62.2%)对他们的药物变化的理解是不充分的。年龄较大、教育程度较低、用药和合并症较多的患者发生非故意差异的风险更高。最常见的非故意差异类型是药物漏用,几乎一半的核对错误可能对患者造成中度或重度伤害。在临床药师针对非故意差异提出的 145 项建议中,有 131 例(90.34%)被临床医生接受并实施。
这些发现进一步支持了在门诊环境中进行用药核对的必要性,以识别差异并提高患者用药安全。